Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Sell

Price to Earnings Rating

Strong Buy

Analyst Rating

Neutral

Simple Moving Average

Strong Buy

Exponential Moving Average

Strong Buy

Relative Strength Index

Strong Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Buy

A

Orchestra BioMed Holdings, Inc. Ordinary Shares (OBIO)

Surgical & Medical Instruments & Apparatus

https://www.orchestrabiomed.com

Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the global commercialization of the products it develops. Orchestra BioMed's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.

150 UNION SQUARE DRIVE
NEW HOPE, PA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

01/27/2023

Market Cap

236,403,750

Shares Outstanding

35,740,000

Weighted SO

35,743,972

Total Employees

N/A

Upcoming Earnings

08/08/2024

Similar Tickers

Beta

0.4410

Last Div

0.0000

Range

4.22-11.69

Chg

0.1900

Avg Vol

138993

Mkt Cap

236403750

Exch

NASDAQ

Country

US

Phone

215 862 5797

DCF Diff

5.4477

DCF

0.8523

Div Yield

0.0000

P/S

113.7103

EV Multiple

-3.6738

P/FV

5.0709

Div Yield %

0.0000

P/E

-4.0260

PEG

-0.1187

Payout

0.0000

Current Ratio

4.5836

Quick Ratio

4.5788

Cash Ratio

1.6349

DSO

14.0452

DIO

73.0000

Op Cycle

87.0452

DPO

6541.8429

CCC

-6454.7976

Gross Margin

0.8316

Op Margin

-28.0361

Pretax Margin

-26.7326

Net Margin

-26.7326

Eff Tax Rate

-0.0278

ROA

-0.7678

ROE

-0.8928

ROCE

-1.0070

NI/EBT

1.0000

EBT/EBIT

0.9535

EBIT/Rev

-28.0361

Debt Ratio

0.0201

D/E

0.0329

LT Debt/Cap

0.0244

Total Debt/Cap

0.0319

Int Coverage

166.0598

CF/Debt

-30.6997

Equity Multi

1.6404

Rec Turnover

25.9875

Pay Turnover

0.0558

Inv Turnover

5.0000

FA Turnover

0.8102

Asset Turnover

0.0287

OCF/Share

-1.2451

FCF/Share

-1.2488

Cash/Share

1.8207

OCF/Sales

-21.4411

FCF/OCF

1.0029

CF Coverage

-30.6997

ST Coverage

-127.3600

CapEx Coverage

-340.2748

Div&CapEx Cov

-340.2748

P/BV

5.0709

P/B

5.0709

P/S

113.7103

P/E

-4.0260

P/FCF

-5.2878

P/OCF

-5.0196

P/CF

-5.0196

PEG

-0.1187

P/S

113.7103

EV Multiple

-3.6738

P/FV

5.0709

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Jan 08, 07:30 Orchestra BioMed Announces Initiation of BACKBEAT Pivotal Study of AVIM Therapy in Hypertensive Pacemaker Patients GlobeNewswire Inc. Nov 09, 16:42 Orchestra BioMed to Present at Upcoming Investor Conferences

Revenue Product Segmentation